US Patent 10632114 Pyruvate kinase activators for use in therapy
Patent 10632114 was granted and assigned to Agios Pharmaceuticals on April, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Apr, 2023
Golden AI
Infobox
Patent Citations
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
106321140
Date of Patent
April 28, 2020
0Patent Application Number
159650880
Date Filed
April 27, 2018
0Official Website
Patent Citations
Patent Citations Received
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 2 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10632114 Pyruvate kinase activators for use in therapy
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10632114
Date of patent
April 28, 2020
Patent application number
15965088
Date Filed
April 27, 2018
Patent citations
Patent primary examiner
Find more entities like US Patent 10632114 Pyruvate kinase activators for use in therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
